Perspectives of autophagy-tethering compounds (ATTECs) in drug discovery
Degrader technologies provide unprecedented strategies to tackle diseases caused by pathogenic proteins that are difficult to target by the traditional inhibitor approach. One pioneering technology, proteolysis-targeting chimera (PROTAC), has revolutionized small-molecule drug discovery. However, PR...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
KeAi Communications Co., Ltd.
2024-03-01
|
| Series: | Medicine Plus |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S295034772300004X |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|